AI ScreeningAI ChatPricing
  1. US-listed companies
  2. FILANA THERAPEUTICS, INC.
  3. Financials
  4. Research & development

FILANA THERAPEUTICS, INC.【FLNA】

Market cap
$106.76M
P/E ratio
SummaryFinancials
Period EndResearch & development (Million USD)YoY (%)
Dec 31, 202470-22.13%
Dec 31, 202389+2911.89%
Dec 31, 20183-61.01%
Dec 31, 20178-17.01%
Dec 31, 20169+0.84%
Dec 31, 20159+24.56%
Dec 31, 20147+48.59%
Dec 31, 20135-35.35%
Dec 31, 20128-8.37%
Dec 31, 20118

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)